Post-stroke cognitive impairment (results of a 5-year follow-up)
https://doi.org/10.14412/2074-2711-2018-1-37-42
Abstract
Prior stroke plays an important role in the development of cognitive impairment (CI), the prevention of which requires detailed study.
Patients and methods. A total of 350 patients (mean age, 65±17.7 years; 49% men) who had experienced a stroke with a small degree of neurological deficit were followed up. Cognitive functions were evaluated using the Mini-Mental State Examination (MMSE), Mattis dementia rating scale, the clock drawing test, the test on memorizing 12 words, and the Schulte table. During 5 years of follow-up, 61 (17.4%) patients died, including 45 (12.8%) from recurrent stroke; 89 recurrent strokes developed.
Results. The first examination did not reveal CI in 59 (17%) patients; 73 (21%) were found to have marked CI (mild or moderate dementia). After 1, 3, and 5years of follow-up, the proportion of patients with marked CI increased up to 23.2, 29.5, and 34.5%, respectively. Within 5 years, there was an average decline of 2 MMSE scores. The maximum decrease in cognitive functions was seen in patients who had experienced a recurrent stroke, but this also occurred in the absence of a stroke. Cognitive functions were substantially better in a group of patients with blood pressure (BP) normalization.
Conclusion. The 5-year follow-up has shown that post-stroke CI gradually progresses, which is associated with the progression of both vascular disease and a concomitant neurodegenerative process. BP normalization during antihypertensive therapy contributes to the prevention of progressive post-stroke CI.
About the Authors
S. V. Verbitskaya
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
Department of Nervous System Diseases and Neurosurgery,
11, Rossolimo St., Moscow 119021
V. A. Parfenov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
Department of Nervous System Diseases and Neurosurgery,
11, Rossolimo St., Moscow 119021
V. A. Reshetnikov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
Department of Public Health and Health Care,
2, Bolshaya Pirogovskaya St., Moscow 119991
V. V. Kozlov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
Department of Public Health and Health Care,
2, Bolshaya Pirogovskaya St., Moscow 119991
A. R. Kabaeva
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Russian Federation
Department of Nervous System Diseases and Neurosurgery,
11, Rossolimo St., Moscow 119021
References
1. O’Brien J, Ames D, Gustafson L, et al, editors. Cerebrovascular disease, cognitive impairment and dementia. Cerebrovascular disease and dementia. 2nd ed. London; NewYork: Martin Dunitz; 2004.
2. Gorelick PB, Scuteri A, Black SE, et al. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2011 Sep;42(9):2672-713. doi: 10.1161/STR. 0b013e3182299496. Epub 2011 Jul 21.
3. Парфенов ВА, Хасанова ДР. Ишемический инсульт. Москва: МИА; 2012. 288 с. [Parfenov VA, Khasanova DR. Ishemicheskii insul't [Ischemic stroke]. Moscow: MIA; 2012. 288 p.]
4. Гусев ЕИ, Боголепова АН. Когнитивные нарушения при цереброваскулярных заболеваниях. Москва: МЕДпресс-информ; 2013. 180 с. [Gusev EI, Bogolepova AN. Kognitivnye narusheniya pri tserebrovaskulyarnykh zabolevaniyakh [Cognitive impairment in cerebrovascular diseases]. Moscow: MEDpress-inform; 2013. 180 p.]
5. Sun JH, Tan L, Yu JT. Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med. 2014 Aug;2(8):80. doi: 10.3978/j.issn.2305-5839.2014.08.05.
6. Delavaran H, Jonsson AC, Lovkvist H, et al. Cognitive function in stroke survivors: a 10-year follow-up study. Acta Neurol Scand. 2017 Sep;136(3): 187-194. doi: 10.1111/ane.12709. Epub 2016 Nov 1.
7. Rist PM, Chalmers J, Arima H, et al. Baseline cognitive function, recurrent stroke, and risk of dementia in patients with stroke. Stroke. 2013 Jul; 44(7):1790-5. doi: 10.1161/STROKEAHA.111. 680728. Epub 2013 May 16.
8. Gutierrez Perez C, Savborg M, Pahlman U, et al. High frequency of cognitive dysfunction before stroke among older people. Int J Geriatr Psychiatry. 2011 Jun;26(6):622-9. doi: 10.1002/gps.2573. Epub 2010 Oct 4.
9. Douiri A, Rudd AG, Wolfe CD. Prevalence of poststroke cognitive impairment: South London Stroke Register 1995-2010. Stroke. 2013 Jan;44(1): 138-45. doi: 10.1161/STROKEAHA.112.670844. Epub 2012 Nov 13.
10. Jokinen H, Melkas S, Ylikoski R, et al. Poststroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015 Sep; 22(9):1288-94. doi: 10.1111/ene.12743. Epub 2015 Jun 4.
11. Jacquin A, Binquet C, Rouaud O, et al. Poststroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke. J Alzheimers Dis. 2014;40(4):1029-38. doi: 10.3233/ JAD-131580.
12. Zekry D, Duyckaerts C, Belmin J, et al. The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging. 2003 Mar-Apr;24(2):213-9.
13. Munsch F, Sagnier S, Asselineau J, et al. Stroke location is an independent predictor of cognitive outcome. Stroke. 2016 Jan;47(1):66-73. doi: 10.1161/ STROKEAHA.115.011242. Epub 2015 Nov 19.
14. Парфенов ВА, Захаров ВВ, Преображенская ИС. Когнитивные расстройства. Москва: Ремедиум; 2014. 224 с. [Parfenov VA, Zakharov VV, Preobrazhenskaya IS. Kognitivnye rasstroistva [Cognitive impairment]. Moscow: Remedium; 2014. 224 p.]
15. Mohd Zulkifly MF, Ghazali SE, Che Din N, et al. The influence of demographic, clinical, psychological and functional determinants on poststroke cognitive impairment at day care stroke center, Malaysia. Malays J Med Sci. 2016 Mar; 23(2):53-64.
16. Arba F, Quinn T, Hankey GJ, et al. Determinants of post-stroke cognitive impairment: analysis from VISTA. Acta Neurol Scand. 2017 Jun;135(6): 603-607. doi: 10.1111/ane.12637. Epub 2016 Jul 13.
17. Вербицкая СВ, Парфенов ВА. Вторичная профилактика инсульта в амбулаторных условиях. Неврологический журнал. 2011;16(1):17-21. [Verbitskaya SV, Parfenov VA. Secondary prevention of stroke in the outpatient setting. Nevrologicheskii zhurnal. 2011;16(1):17-21. (In Russ.)].
18. Cumming TB, Brodtmann A, Darby D, et al. The importance of cognition to quality of life after stroke. J Psychosom Res. 2014 Nov;77(5):374-9. doi: 10.1016/j.jpsychores.2014.08.009. Epub 2014 Aug 29.
19. Qu Y, Zhuo L, Li N, et al. Prevalence of poststroke cognitive impairment in China: a community-based, cross-sectional study. PLoS One. 2015 Apr 13;10(4):e0122864. doi: 10.1371/journal.pone. 0122864. eCollection 2015.
20. Chen X, Duan L, Han Y, et al. Predictors for vascular cognitive impairment in stroke patients. BMC Neurol. 2016 Jul 26;16:115. doi: 10.1186/ s12883-016-0638-8.
21. Yamamoto Y, Nagakane Y, Yasuhiro T, et al. High morning and bedtime home blood pressures strongly predict for post-stroke cognitive impairment. J Stroke Cerebrovasc Dis. 2016 Aug;25(8): 1856-63. doi: 10.1016/j.jstrokecerebrovasdis.2016. 04.001. Epub 2016 May 2.
22. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009 Nov;8(11): 1006-18. doi: 10.1016/S1474-4422(09)70236-4. Epub 2009 Sep 24.
23. Gemmell E, Tam E, Allan L, et al. Neuron volumes in hippocampal subfields in delayed poststroke and aging-related dementias. J Neuropathol Exp Neurol. 2014 Apr;73(4):305-11. doi: 10.1097/ NEN.0000000000000054.
24. Ivan CS, Seshadri S, Beiser A, et al. Dementia after stroke: the Framingham Study. Stroke. 2004 Jun;35(6):1264-8. Epub 2004 Apr 29.
25. Mahon S, Parmar P, Barker-Collo S, et al. Determinants, prevalence, and trajectory of longterm post-stroke cognitive impairment. Results from a 4-year follow-up of the ARCOS-IV study. Neuroepidemiology. 2017 Nov 16;49(3-4):129-134. doi: 10.1159/000484606. [Epub ahead of print].
26. Ankolekar S, Geeganage C, Anderton P, et al. Clinical trials for preventing post stroke cognitive impairment. J Neurol Sci. 2010;299(1-2):168-74. doi: 10.1016/j.jns.2010.08.052. Epub 2010 Sep 19.
27. Levi Marpillat N, Macquin-Mavier I, Tropeano AI, et al. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens. 2013 Jun;31(6):1073-82. doi: 10.1097/HJH.0b013e3283603f53.
28. Staessen J, Fagard R, Thijs L, et al. Randomised double blind comparsion of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997 Sep 13;350(9080): 757-64.
29. PROGRESS Collaborative Group. Randomised trial of a perindopril-based bloodpressure-lowering regimen among 6105 individuals with previous stroke or transient schaemic attack. Lancet. 2001 Sep 29;358(9287):1033-41.
30. Bosch J, Yusuf S, Pogue J, et al; HOPE Investigators. Heart outcomes prevention evaluation. Use of ramipril in preventing stroke: double blind randomised trial. BMJ. 2002 Mar 23; 324(7339):699-702.
31. Skoog I, Lithell H, Hansson L, et al. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on cognition and prognosis in the elderly (SCOPE). Am J Hypertens. 2005 Aug;18(8): 1052-9.
32. Gorelick PB. Blood Pressure and the Prevention of Cognitive Impairment. JAMA Neurol. 2014 Oct;71(10):1211-3. doi: 10.1001/jamaneurol.2014.2014.
33. Solomon A, Mangialasche F, Richard E, et al. Advances in the prevention of Alzheimer’s disease and dementia. J Intern Med. 2014 Mar;275(3): 229-50. doi: 10.1111/joim.12178.
34. Ihle-Hansen H, Thommessen B, Fagerland MW, et al. Blood pressure control to prevent decline in cognition after stroke. Vasc Health Risk Manag. 2015 Jun 9;11:311-6. doi: 10.2147/VHRM.S82839 eCollection 2015.
35. Peng J, Lu F, Wang Z, et al. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study. J Am Med Dir Assoc. 2014 Dec; 15(12):904-10. doi: 10.1016/j.jamda.2014.07.005. Epub 2014 Sep 18.
36. Mossello E, Pieraccioli M, Nesti N, et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med. 2015 Apr;175(4): 578-85. doi: 10.1001/jamainternmed.2014.8164.
37. Gottesman RF, Schneider AL, Albert M, et al. Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA Neurol. 2014 Oct;71(10):1218-27. doi: 10.1001/jamaneurol.2014.1646.
38. Bath PM, Scutt P, Blackburn DJ, et al. Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: Main results from the pilot ‘Prevention of Decline in Cognition after Stroke Trial’ (PODCAST) Randomised Controlled Trial. PLoS One. 2017 Jan 17;12(1):e0164608. doi: 10.1371/journal.pone. 0164608. eCollection 2017.
Review
For citations:
Verbitskaya S.V., Parfenov V.A., Reshetnikov V.A., Kozlov V.V., Kabaeva A.R. Post-stroke cognitive impairment (results of a 5-year follow-up). Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):37-42. (In Russ.) https://doi.org/10.14412/2074-2711-2018-1-37-42
Views: 988
Email this article 